- Home
- MDGL vs EHC Comparison
MDGL vs EHC Comparison
Compare MDGL & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | EHC |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 10.5B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MDGL | EHC |
|---|---|---|
| Price | $435.90 | $100.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $674.45 | $143.29 |
| AVG Volume (30 Days) | 327.9K | ★ 917.8K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | ★ 41.32 | 24.22 |
| EPS | N/A | ★ 5.54 |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.70 | $9.38 |
| Revenue Next Year | $46.88 | $8.12 |
| P/E Ratio | ★ N/A | $18.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $265.00 | $92.77 |
| 52 Week High | $615.00 | $127.99 |
Technical Indicators
Market Signals| Indicator | MDGL | EHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 36.03 |
| Support Level | $416.43 | $98.24 |
| Resistance Level | $446.51 | $109.14 |
| Average True Range (ATR) | 15.97 | 2.82 |
| MACD | 2.59 | -1.07 |
| Stochastic Oscillator | 56.64 | 9.72 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.